Key Insights

Highlights

Success Rate

86% trial completion

Published Results

30 trials with published results (16%)

Research Maturity

88 completed trials (46% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.3%

14 terminated out of 191 trials

Success Rate

86.3%

-0.3% vs benchmark

Late-Stage Pipeline

13%

25 trials in Phase 3/4

Results Transparency

34%

30 of 88 completed with results

Key Signals

30 with results86% success14 terminated

Data Visualizations

Phase Distribution

141Total
Not Applicable (80)
Early P 1 (1)
P 1 (13)
P 2 (22)
P 3 (19)
P 4 (6)

Trial Status

Completed88
Recruiting45
Unknown20
Terminated14
Not Yet Recruiting11
Active Not Recruiting7

Trial Success Rate

86.3%

Benchmark: 86.6%

Based on 88 completed trials

Clinical Trials (191)

Showing 20 of 20 trials
NCT06570681Not ApplicableRecruiting

Video Call Assisted Assessment of Acute Stroke

NCT07587242Phase 3Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

NCT04512690Not ApplicableCompleted

Spinal Cord Stimulation for Restoration of Arm and Hand Function in People With Subcortical Stroke

NCT06817577Phase 1Active Not Recruiting

NG004 in Spinal Cord Injury Patients

NCT04539002Not ApplicableCompleted

Aerobic Exercise for Remyelination in Multiple Sclerosis

NCT05508789Phase 3Active Not Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT05744310Not ApplicableRecruiting

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

NCT05479981Phase 2Completed

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

NCT03911388Phase 1Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT07802366Not ApplicableNot Yet Recruiting

Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria

NCT07250737Unknown

Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

NCT05126758Phase 3Active Not Recruiting

A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

NCT06193252Not ApplicableRecruiting

Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

NCT06993142Not ApplicableRecruiting

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

NCT06121336Recruiting

PRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke

NCT00690196Not ApplicableCompleted

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

NCT07759115Not ApplicableRecruiting

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

NCT03962127Active Not Recruiting

MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway

NCT05007353Not ApplicableCompleted

The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study

NCT07626229Not ApplicableCompletedPrimary

Domain-Specific Large Language Model Assistance for Emergency Neurological Diagnosis and Treatment(DEMAND)

Scroll to load more

Research Network

Activity Timeline